CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Study Of The Toxicities, Biologic And Clinical Effects Of Daily 5 Aza 2'Deoxycytidine (DAC), NSC 127716 (IND 50733) For Four Weeks In Patients With Advanced Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00030615
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:22.091673+00:00
Published At: 2013-02-07T00:00:00+00:00
Record Updated At: 2013-02-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Male Breast Cancer", "Recurrent Bladder Cancer", "Recurrent Breast Cancer", "Recurrent Melanoma", "Stage III Melanoma", "Stage IV Bladder Cancer", "Stage IV Breast Cancer", "Stage IV Melanoma", "Unspecified Adult Solid Tumor, Protocol Specific"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-02-07"
protocolSection.identificationModule.nctId: "NCT00030615"
protocolSection.identificationModule.officialTitle: "A Phase I Study Of The Toxicities, Biologic And Clinical Effects Of Daily 5 Aza 2\u0027Deoxycytidine (DAC), NSC 127716 (IND 50733) For Four Weeks In Patients With Advanced Malignancies"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.